SHSang Won Han

Sang Won Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sang Won Han has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cumulative Smoking Exposure and Carotid Plaque in Ischemic Stroke Without Traditional Risk Factors

    by Hyo Jeong Choi, Youngchan Jung, Jin Kim, Sang Won Han

    Background: While smoking is a known risk factor for stroke, its dose-dependent structural impact on the carotid arteries in patients free of standard modifiable risk factors (SMoRFs) remains poorly quantified. This study investigated the association between cumulative tobacco exposure, carotid intima-media thickness (CIMT), and carotid plaque formation in SMoRF-free patients with ischemic stroke or transient ischemic attack (TIA).Methods: This retrospective, cross-sectional observational study screened 2,810 consecutive patients with first-ever ischemic stroke or TIA. Analysis included 204 patients entirely free of SMoRFs except smoking, comparing current smokers with never-smokers. B-mode ultrasound evaluated CIMT and the carotid plaques. Cumulative pack-years of smoking (PYS) were calculated.Results: Among the 204 patients, 72 (35.3%) were current smokers. The smoking group was significantly younger (mean age 55.4 vs. 67.3 years; p<0.001) and predominantly male (88.9% vs. 37.9%; p<0.001). Carotid plaque prevalence (44.4% vs. 54.5%; p=0.168) and age-adjusted CIMT did not differ significantly by smoking status. In an unadjusted stratified analysis of current smokers, carotid plaque prevalence increased in a dose-dependent manner with cumulative exposure, rising from 11.8% in light smokers (<23 PYS) to 77.8% in extreme smokers (≥36 PYS; p<0.001). However, this categorical, dose-dependent association was not significant in age-adjusted logistic regression. (overall effect, p=0.312). Point estimates increased across strata, but confidence intervals were wide and crossed 1.0 (extreme vs. light smokers: odds ratio 20.78; 95% confidence interval, 0.67–644.48; p=0.084).Conclusion: In SMoRF-free ischemic stroke patients, cumulative smoking exposure showed a dose-dependent trend toward higher carotid plaque prevalence. However, this association did not remain significant after age adjustment, given the marked age increase with smoking intensity. These hypothesis-generating findings require confirmation in larger, age-matched studies.

  • Open Access

    Marchiafava–Bignami disease

    by Hyo Jeong Choi, Sang Won Han

  • Open Access

    Internal Jugular Vein Phlebectasia

    by Sun Yoon Chung, Sang Won Han

  • Open Access

    Association of Cerebral Artery Stenosis with Blood Viscosity in Patients with Transient Ischemic Attack

    by Young Chan Jung, Sang Won Han, Joong Hyun Park

    Background: Blood viscosity (BV) reflects blood thickness and stickiness, crucial for vascular health. Elevated BV is linked to stroke risk factors, suggesting a role in transient ischemic attacks (TIA).Methods: This retrospective observational study investigated BV levels in TIA patients with and without cerebral artery stenosis. Patients admitted within 24 hours of symptom onset between March 2017 and December 2021 were included. Baseline characteristics, including demographics and vascular risk factors, were assessed. BV measurements were obtained within 24 hours of symptom onset using a scanning capillary-tube viscometer. Patients were categorized into TIA groups based on the presence or absence of cerebral artery stenosis.Results: Of the 153 TIA patients screened, 86 were included for analysis. The mean age was 62.6 years, with a predominance of hypertension (59%) and dyslipidemia (45%). Patients with cerebral artery stenosis (TIA-AT group, n=56) exhibited significantly higher BV levels within 24 hours of symptom onset compared to those without stenosis (TIA-E group, n=30). This finding suggests a potential link between underlying pathophysiological mechanisms of TIA and BV levels.Conclusion: Despite the limitations of a single-center, retrospective study, this research suggests that there is evidence of increased blood viscosity in patients with TIA who have cerebral artery stenosis, implying that blood viscosity may play a role in the pathophysiology of TIA. Further research involving larger cohorts is warranted to elucidate the precise mechanisms linking BV to TIA and to validate its utility as a prognostic marker and therapeutic target in TIA management.


  • Open Access

    Variation in blood viscosity based on the potential cause of stroke of undetermined etiology

    by Jinyoung Oh, Youngchan Jung, Jin Kim, Sun Ki Min, Sang Won Han, Jong Sam Baik

    Background: This study investigated potential differences in blood viscosity (BV) among patients with stroke of undetermined etiology, negative evaluation (SUDn), specifically those with potential atherothrombosis (SUDn-AT) and those with possible embolism (SUDn-E).Methods: This single-center study employed a retrospective observational design. The participants were patients over 20 years old with the SUDn stroke subtype who were admitted within 5 days of symptom onset. These patients were categorized as SUDn-AT or SUDn-E. Patients in the SUDn-AT group had nonsignificant stenosis (<50%) of a major brain artery relevant to their symptoms and exhibited one or more signs of systemic atherosclerosis, including atherosclerosis of at least one major brain artery other than those clinically relevant, coronary artery disease, and/or peripheral artery disease. For the SUDn-E group, the SUDn criteria from the TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification system were strictly applied.Results: The final analysis included 153 patients, with 104 (68%) classified as SUDn-E and the remaining 32% as SUDn-AT. Patients in the SUDn-AT group had a higher systolic BV (P=0.012) and diastolic BV (P=0.020) than those in the SUDn-E group. Multivariable logistic regression analysis revealed that age (odds ratio [OR], 1.08; 95% confidence interval [CI], 1.03–1.13; P=0.003), systolic BV (OR, 3.11; 95% CI, 1.41–6.85; P=0.005), and diastolic BV (OR, 1.08; 95% CI, 1.02–1.14; P=0.009) were associated with SUDn-AT.Conclusions: Within the TOAST system, two SUDn entities may be distinguishable, with potentially different underlying etiologies: atherothrombosis and embolic stroke of undetermined source.


  • Open Access

    Cerebral Venous Thrombosis Combined with Spontaneous Intracranial Hypotension: A Case Report and Review of the Literature

    by Jinyoung Oh, Sang Won Han, Sun Yoon Chung

    Several cases of cerebral venous thrombosis (CVT) due to spontaneous intracranial hypotension (SIH) have been reported, with an estimated occurrence rate of 1–2% among patients with decreased intracranial pressure. However, the causal relationship between SIH and CVT as a potential risk factor is not well understood. According to the Monro-Kellie principle, this is thought to be caused by compensatory expansion of the cerebral venous system, damage to the intravenous wall due to changes in cerebral buoyancy, or increased venous blood viscosity. Although anticoagulation therapy is typically the first choice of treatment for patients diagnosed with CVT, considering the potential risk of intracerebral hemorrhage in patients with CVT secondary to SIH is important. We report the case of a patient who developed CVT as a complication of SIH and discuss its mechanisms and treatment options. Early identification and appropriate treatment can lead to successful outcomes and the prevention of potential complications.


  • Open Access

    The Impact of Prior Antithrombotic Use on Blood Viscosity in Cardioembolic Stroke with Non-Valvular Atrial Fibrillation

    by Yo-Han Jung, Sang-Won Han, Joong-Hyun Park

    Although clinical studies have demonstrated that prior use of antiplatelets was associated with decreased blood viscosity (BV) in patients with acute ischemic stroke, the impact of previous anticoagulant use on blood viscosity in cardioembolic stroke with non-valvular AF (NVAF) has not yet been clearly studied. This single-center retrospective observational study aimed to determine the impact of prior antithrombotic (antiplatelet and anticoagulant) use on BV in patients with cardioembolic stroke (CES) due to NVAF. Patients with CES and NVAF were analyzed with the following inclusion criteria: (1) patients over 20 years of age admitted within five days of stroke onset; (2) ischemic stroke presumably due to an NVAF-derived embolus; (3) compatible cortical/subcortical lesion on brain computed tomography or magnetic resonance imaging; (4) hemoglobin level of 10–18 mg/dL; and (5) receiving antiplatelets within five days or anticoagulants within two days if previously medicated. From the screening of 195 patients (22% of the total stroke population during the study period) who had experienced ischemic stroke with AF, 160 were included for the final analysis. Eighty-nine patients (56%) were taking antithrombotics (antiplatelet, 57%; warfarin, 13%; NOACs, 30%) regularly. Compared to patients without previous antithrombotic use, those with previous antithrombotic use (antiplatelets, warfarin, and NOACs) were significantly associated with decreased systolic BV (SBV) and diastolic BV (DBV) (p < 0.036). In multiple linear regression analysis, hematocrit (Hct) level and prior antithrombotic use were significantly associated with decreased SBV and DBV. Hct was positively correlated with increased SBV and DBV. In Hct-adjusted partial correlation analysis, prior uses of any antithrombotic agents were associated with decreased SBV (r < −0.270, p < 0.015) and DBV (r < −0.183, p < 0.044). In conclusion, this study showed that prior antithrombotic use (antiplatelets, VKAs, and NOACs) was associated with decreased SBV and DBV in patients presenting with acute CES secondary to NVAF. Our results indicated that previous use of NOACs may be a useful hemorheological parameter in patients with acute CES due to NVAF. Accumulation of clinical data from a large number of patients with the risk of stroke occurrence, initial stroke severity, and functional outcome is necessary to assess the usefulness of BV.


  • Impact of Renal Function on Short-Term Outcome After Reperfusion Therapy in Patients With Ischemic Stroke

    by Hyungjong Park, Young Dae Kim, Hyo Suk Nam, Joonsang Yoo, Sung-Il Sohn, Jeong-Ho Hong, Byung Moon Kim, Dong Joon Kim, Oh Young Bang, Woo-Keun Seo, et al.

    Background: A high and low estimated glomerular filtration rate (eGFR) could affect outcomes after reperfusion therapy for ischemic stroke. This study aimed to determine whether renal function based on eGFR affects mortality risk in patients with ischemic stroke within 6 months following reperfusion therapy. Methods: This prospective registry–based cohort study included 2266 patients who received reperfusion therapy between January 2000 and September 2019 and were registered in the SECRET (Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy) study or the Yonsei Stroke Cohort. A high and low eGFR were based on the Chronic Kidney Disease Epidemiology Collaboration equation and defined, respectively, as the 5th and 95th percentiles of age- and sex-specific eGFR. Occurrence of death within 6 months was compared among the groups according to their eGFR such as low, normal, or high eGFR. Results: Of the 2266 patients, 2051 (90.5%) had a normal eGFR, 110 (4.9%) a low eGFR, and 105 (4.6%) a high eGFR. Patients with high eGFR were younger or less likely to have hypertension, diabetes, or atrial fibrillation than the other groups. Active cancer was more prevalent in the high-eGFR group. During the 6-month follow-up, there were 24 deaths (22.9%) in the high-eGFR group, 37 (33.6%) in the low-eGFR group, and 237 (11.6%) in the normal-eGFR group. After adjusting for variables with P P =0.001) and low eGFR (HR, 2.29 [95% CI, 1.41–3.72]; P =0.001). These associations persisted regardless of treatment modality or various baseline characteristics. Conclusions: High eGFR as well as low eGFR were independently associated with 6-month mortality after reperfusion therapy. Kidney function could be considered a prognostic factor in patients with ischemic stroke after reperfusion therapy.


  • Open Access

    Association between CHADS2, CHA2DS2-VASc, ATRIA, and Essen Stroke Risk Scores and Functional Outcomes in Acute Ischemic Stroke Patients Who Received Endovascular Thrombectomy

    by Hyung Jun Kim, Moo-Seok Park, Joonsang Yoo, Young Dae Kim, Hyungjong Park, Byung Moon Kim, Oh Young Bang, Hyeon Chang Kim, Euna Han, Dong Joon Kim, et al.

    Background: CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores are used to estimate thromboembolism risk. We aimed to investigate the association between unfavorable outcomes and stroke risk scores in patients who received endovascular thrombectomy (EVT). Methods: This study was performed using data from a nationwide, multicenter registry to explore the selection criteria for patients who would benefit from reperfusion therapies. We calculated pre-admission CHADS2, CHA2DS2-VASc, ATRIA, and Essen scores for each patient who received EVT and compared the relationship between these scores and 3-month modified Rankin Scale (mRS) records. Results: Among the 404 patients who received EVT, 213 (52.7%) patients had unfavorable outcomes (mRS 3–6). All scores were significantly higher in patients with unfavorable outcomes than in those with favorable outcomes. Multivariable logistic regression analysis indicated that CHADS2 and the ATRIA score were positively correlated with unfavorable outcomes after adjusting for body mass index and variables with p < 0.1 in the univariable analysis (CHADS2 score: odds ratio [OR], 1.484; 95% confidence interval [CI], 1.290–1.950; p = 0.005, ATRIA score, OR, 1.128; 95% CI, 1.041–1.223; p = 0.004). Conclusions: The CHADS2 and ATRIA scores were positively correlated with unfavorable outcomes and could be used to predict unfavorable outcomes in patients who receive EVT.